benign prostatic hyperpIasia
Conditions
Interventions
Lingze tabIets combined with Doxazosin mesylate group:oral Lingze tabIets combined with Doxazosin mesylate
Doxazosin mesylate group:Doxazosin mesylate
Sponsors
First Affiliated Hospital of Gannan Medical University
Eligibility
Sex/Gender
Male
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 50~70 years old benign prostatic hyperpIasia of kidney deficiency and blood stasis type Not using medication for prostate hyperplasia before or within 3 months of treatment
Exclusion criteria
Exclusion criteria: Patients with acute or chronic prostatitis, prostate cancer, or previous prostate surgery Patients with acute and chronic urinary retention, urinary tract infection, urinary stone, urinary tumor and other diseases requiring other treatment Neurogenic bladder, urinary diversion, urethral stricture People who are allergic to the ingredients in doxazosin or Lingze tablets There are indications for surgical treatment: repeated urinary retention, repeated urinary tract infection, secondary hydronephrosis and renal insufficiency; Patients with poor control of other severe primary diseases combined Low blood pressure; Mental illness or lack of autonomy; History of alcohol and drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IPSS score difference; | — |
Secondary
| Measure | Time frame |
|---|---|
| QoL score difference;traditional chinese medicine syndrome score difference; | — |
Countries
China
Contacts
Public Contactzhang zhaolin
No. 128 Jinling Road, Ganzhou, Jiangxi, China
Outcome results
None listed